FDA Approves DUCORD Product from Duke for Stem Cell Transplants
October 8, 2012 - (Duke Health) - "Duke University School of Medicine has received approval from the Food and Drug Administration to market DUCORD, a stem cell product derived from umbilical cord blood, for use in transplants between unrelated donors and recipients." Read Full Article
